AquaBounty Technologies, Inc. (AQB)
1.14
+0.01
(+0.88%)
USD |
NASDAQ |
Sep 18, 16:00
1.13
-0.01
(-0.88%)
After-Hours: 20:00
AquaBounty Technologies Enterprise Value : 3.982M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 3.982M |
| September 17, 2026 | 3.931M |
| September 16, 2026 | 3.828M |
| September 15, 2026 | 3.776M |
| September 14, 2026 | 4.034M |
| September 11, 2026 | 4.394M |
| September 10, 2026 | 3.570M |
| September 09, 2026 | 3.570M |
| September 08, 2026 | 3.931M |
| September 04, 2026 | 4.034M |
| September 03, 2026 | 4.188M |
| September 02, 2026 | 4.188M |
| September 01, 2026 | 4.240M |
| August 31, 2026 | 4.677M |
| August 28, 2026 | 4.548M |
| August 27, 2026 | 4.857M |
| August 26, 2026 | 4.754M |
| August 25, 2026 | 4.960M |
| August 24, 2026 | 4.857M |
| August 21, 2026 | 4.857M |
| August 20, 2026 | 4.857M |
| August 19, 2026 | 4.960M |
| August 18, 2026 | 5.218M |
| August 17, 2026 | 5.320M |
| August 14, 2026 | 5.758M |
| Date | Value |
|---|---|
| August 13, 2026 | 5.835M |
| August 12, 2026 | 5.218M |
| August 11, 2026 | 5.784M |
| August 10, 2026 | 5.166M |
| August 07, 2026 | 4.137M |
| August 06, 2026 | 3.622M |
| August 05, 2026 | 3.210M |
| August 04, 2026 | 2.798M |
| August 03, 2026 | 2.848M |
| July 31, 2026 | 2.776M |
| July 30, 2026 | 2.798M |
| July 29, 2026 | 2.847M |
| July 28, 2026 | 2.850M |
| July 27, 2026 | 2.747M |
| July 24, 2026 | 2.798M |
| July 23, 2026 | 2.958M |
| July 22, 2026 | 2.978M |
| July 21, 2026 | 3.056M |
| July 20, 2026 | 2.991M |
| July 17, 2026 | 3.107M |
| July 16, 2026 | 3.107M |
| July 15, 2026 | 3.210M |
| July 14, 2026 | 3.056M |
| July 13, 2026 | 3.216M |
| July 10, 2026 | 3.159M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.815B |
| Agenus, Inc. | 599.19M |
| Alnylam Pharmaceuticals, Inc. | 31.72B |
| Amgen, Inc. | 251.80B |
| Anika Therapeutics, Inc. | 265.34M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.332M |
| Total Expenses (Quarterly) | 1.332M |
| EPS Diluted (Quarterly) | -0.3169 |
| Earnings Yield | -401.9% |
| Normalized Earnings Yield | -421.21 |